Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation.
Nishimoto M, Koh H, Tokuwame A, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Koh S, Yoshimura T, Nanno S, Nakamae M, Hirose A, Nakashima Y, Nakane T, Hino M, Nakamae H. Nishimoto M, et al. Among authors: kuno m. Br J Clin Pharmacol. 2017 Sep;83(9):2000-2007. doi: 10.1111/bcp.13303. Epub 2017 May 24. Br J Clin Pharmacol. 2017. PMID: 28407449 Free PMC article.
Characterization of readmission after allogeneic hematopoietic cell transplantation.
Yamaguchi K, Inamoto Y, Tajima K, Sakatoku K, Kuno M, Kawajiri A, Takemura T, Tanaka T, Ito A, Kurosawa S, Kim SW, Fukuda T. Yamaguchi K, et al. Among authors: kuno m. Bone Marrow Transplant. 2021 Jun;56(6):1335-1340. doi: 10.1038/s41409-020-01190-w. Epub 2021 Jan 7. Bone Marrow Transplant. 2021. PMID: 33414511
Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation.
Tanizawa N, Koh H, Okamura H, Yamamoto K, Makuuchi Y, Kuno M, Takakuwa T, Koh S, Nanno S, Nishimoto M, Hirose A, Nakamae M, Nakashima Y, Nakane T, Hino M, Nakamae H. Tanizawa N, et al. Among authors: kuno m. Transplant Cell Ther. 2021 May;27(5):437.e1-437.e9. doi: 10.1016/j.jtct.2021.01.021. Epub 2021 Jan 28. Transplant Cell Ther. 2021. PMID: 33965190 Free article.
Increasing numbers of CD19 + CD24highCD38high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune thrombocytopenia.
Hayashi T, Nakamae H, Takeda S, Nakashima Y, Koh H, Nishimoto M, Okamura H, Nanno S, Makuuchi Y, Kuno M, Nakamae M, Hirose A, Hino M. Hayashi T, et al. Among authors: kuno m. Int J Hematol. 2021 Nov;114(5):580-590. doi: 10.1007/s12185-021-03192-w. Epub 2021 Jul 26. Int J Hematol. 2021. PMID: 34309815
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation.
Nakamae H, Nakane T, Okamura H, Koh H, Nakashima Y, Hirose A, Nakamae M, Nishimoto M, Kuno M, Makuuchi Y, Harada N, Takakuwa T, Hino M. Nakamae H, et al. Among authors: kuno m. Int J Hematol. 2022 Jan;115(1):77-86. doi: 10.1007/s12185-021-03228-1. Epub 2021 Sep 29. Int J Hematol. 2022. PMID: 34586587 Clinical Trial.
403 results